Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes

Area of Science:

• Cardiovascular Biology
• Stem Cell Research
• Molecular Cardiology

Background:

• Cardiac hypertrophy is a hallmark of cardiovascular diseases, but its mechanisms in humans remain unclear.
• A lack of human cardiomyocyte models hinders the study of cardiac hypertrophy.
• Understanding mechanotransduction is crucial for developing treatments.

Purpose of the Study:

• To establish and validate a human cardiomyocyte-based in vitro model for studying cardiac hypertrophy.
• To investigate the effects of mechanical stretch on human embryonic stem cell-derived cardiomyocytes (hESC-CMs).
• To explore the molecular underpinnings of cardiac hypertrophy using this new model.

Main Methods:

• Culturing and differentiating human embryonic stem cells into cardiomyocytes (hESC-CMs).
• Subjecting hESC-CMs to cyclic mechanical stretch to simulate in vivo conditions.
• Analyzing structural, functional, and gene expression changes in stretched hESC-CMs.

Main Results:

• hESC-CMs subjected to cyclic stretch exhibited key features of cardiac hypertrophy.
• Observed changes included structural remodeling, functional alterations, and modified gene expression.
• The model successfully recapitulated aspects of diseased myocardium.

Conclusions:

• Mechanical stretch of hESC-CMs provides a viable in vitro model for cardiac hypertrophy research.
• This model offers insights into mechanotransduction pathways involved in cardiac hypertrophy.
• It serves as a foundation for developing new pharmacological therapies and identifying biomarkers for cardiac dysfunction.